RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
RESMED INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$239.77+0.80 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $34.79B
- P/E (TTM)
- 23.0
- Dividend yield
- 1.00%
RESMED INC revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $4.98B | $4.50B | $4.10B | $3.73B | – | – | – | – | – | – | 88.0% | +10.5% |
| Residential Care Software | $675.81M | $641.44M | $584.13M | $497.98M | – | – | – | – | – | – | 12.0% | +5.4% |
| Sleep and Respiratory Care | – | – | – | $3.73B | $3.18B | $2.82B | $2.60B | $2.33B | $2.18B | – | – | – |
| Software as a Service | – | – | – | – | $400.83M | $373.59M | $354.63M | $275.79M | $157.00M | – | – | – |
| Software as a Service | – | – | $584.13M | $497.98M | $400.83M | $373.59M | – | – | – | – | – | – |
| Sleep and Respiratory Care | – | – | $4.10B | $3.73B | $3.18B | – | – | – | – | – | – | – |
| Software As A Service Before Deferred Revenue Adjustment [Member] | – | – | – | – | – | $373.59M | $356.73M | $281.14M | $157.00M | – | – | – |
| Operating income | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $2.20B | $1.96B | $1.68B | $1.45B | – | – | – | – | – | – | +12.2% |
| Residential Care Software | $217.73M | $205.00M | $154.45M | $115.66M | – | – | – | – | – | – | +6.2% |
| Sleep and Respiratory Care | – | – | – | $1.50B | $1.31B | $1.17B | $934.70M | $766.07M | $656.31M | – | – |
| Software as a Service | – | – | – | – | $93.82M | $93.04M | $82.15M | $74.89M | $55.22M | – | – |
| Software as a Service | – | – | $154.45M | $115.66M | $93.76M | $92.36M | – | – | – | – | – |
| Sleep and Respiratory Care | – | – | $1.68B | $1.45B | $1.28B | – | – | – | – | – | – |
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $4.98B | $4.50B | $4.10B | $3.73B | – | – | – | – | – | – | 88.0% | +10.5% |
| Residential Care Software | $675.81M | $641.44M | $584.13M | $497.98M | – | – | – | – | – | – | 12.0% | +5.4% |
| Masks And Other Accessories [Member] | – | – | – | – | – | – | – | – | $879.60M | $767.70M | – | – |
| Devices | – | – | – | – | – | – | – | – | $1.30B | $1.16B | – | – |
| Sleep and Respiratory Care | – | – | $4.10B | $3.73B | $3.18B | $2.82B | $2.60B | $2.33B | $2.18B | – | – | – |
| Software as a Service | – | – | – | – | $400.83M | $373.59M | $354.63M | $275.79M | $157.00M | – | – | – |
| Software as a Service | – | – | $584.13M | $497.98M | $400.83M | $373.59M | – | – | – | – | – | – |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S.A [Member] | $3.56B | $3.29B | $2.98B | $2.72B | $2.25B | $1.96B | $1.83B | $1.59B | $1.35B | $1.23B | 63.0% | +8.4% |
| Rest of the World | $2.09B | $1.86B | $1.71B | – | – | – | – | – | – | – | 37.0% | +12.4% |
| Germany | – | – | – | – | – | – | – | – | – | $153.28M | – | – |
| Rest of the World | – | $1.86B | $1.71B | $1.50B | $1.33B | $1.23B | $1.13B | $1.02B | $994.98M | $837.50M | – | – |
| Global revenue | – | – | $4.69B | $4.22B | $3.58B | $3.20B | $2.96B | $2.61B | $2.34B | $2.07B | – | – |
| U.S., Canada and Latin America | – | – | – | – | $2.38B | $2.08B | $1.93B | $1.70B | $1.45B | $1.31B | – | – |
From the segment and revenue-disaggregation notes of Resmed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.